CAPVEST to acquire STADA GROUP

CAPVEST has agreed to acquire STADA GROUP in a transaction announced on 11 November 2025. The deal involves a company operating within the pharmaceutical manufacturing sector, specifically classified under NaceV2Sector_C_21.20. The specific financial value of the acquisition has not been disclosed to the public, and the consideration structure remains unreported. No details regarding the target country of origin were provided in the available records.

The transaction is currently in the review phase with regulatory bodies. As the deal type was not explicitly categorised in the source data, the specific nature of the buyer, whether a management buyout or buy-in, remains undefined. The completion date is not yet confirmed, and the final status of the agreement depends on the outcome of the ongoing regulatory assessment. Further updates regarding the closing of the deal will follow once the necessary approvals are granted.